In Gabon, few data exist on extended-spectrum beta-lactamases-producing Enterobacteriaceae (ESBL-PE). This study investigated ESBL-PE prevalence and the associated resistance genes in clinical samples (n = 5,956) and anal swabs (n = 78) analyzed in eight hospitals and a medical analysis laboratory in Gabon from January 2016 to March 2018. Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) mass spectrometry analysis identified 790 Enterobacteriaceae isolates (n = 712 clinical samples and n = 78 fecal samples). ESBL-PE prevalence (Müller-Hinton agar disk diffusion method and double-disk synergy test) was 11.8% (84/712) in clinical samples (15.5% from inpatients and 7.1% from outpatients; p < 0.05) and 16.7% (13/78) in carriage isolates. Most ESBL-PE were isolated from urine samples (46/84). In clinical and carriage ESBL-PE isolates, Escherichia coli was predominant (42.8% and 61.5%; phylogroups A, B1, B2, and D), followed by Klebsiella pneumoniae (41.7% and 23.1%). Multiplex PCR and bi-directional sequencing showed that CTX-M group 1 (blaCTX-M-15) was predominant in clinical and carriage ESBL-PE (94% and 92.3%) among which 85.7% and 92.3% also harbored one to three β-lactamase-encoding genes (blaTEM-1, blaOXA-1, or blaSHV-1). Resistance genes were detected in all hospitals in Gabon. ESBL-PE prevalence in Gabon has not reached alarming levels yet, but corrective and monitoring measures are needed to curb their emergence.
Get full access to this article
View all access options for this article.
References
1.
ChoiS.H., LeeJ.E, ParkS.J, et al.2008. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase: implications for antibiotic use. Antimicrob. Agents Chemother. 52:995–1000.
2.
Livermore, D.M. 1995. beta-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557–584.
3.
PatersonD.L., and BonomoR.A.. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657–686.
4.
Bradford, P.A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933–951.
5.
SchwaberM.J., Navon-VeneziaS., SchwartzD., and CarmeliY.. 2005. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 49:2137–2139.
6.
CantónR., NovaisA., ValverdeA., et al.2008. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol. Infect. 14:144–153.
7.
HawkeyP.M., and LivermoreD.M.. 2012. Carbapenem antibiotics for serious infections. BMJ, 344:e3236.
8.
PitoutJ.D., and LauplandK.B.. 2008. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159–166.
TansarliG.S., PoulikakosP., KapaskelisA., and FalagasM.. 2014. Proportion of extended-spectrum β-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence—systematic review. J. Antimicrob. Chemother. 69:1177–1184.
11.
NdirA.2015. Epidemiology and medico-economic impact of hospital infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in Senegal [Thesis] [in French]. University Pierre et Marie Curie-Paris VI, Paris,, France, p. 135.
12.
MuvunyiC.M., MasaisaF., BayinganaC., MutesaL., MusemakweriA., and MuhirwaG.. 2011. Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines. Am. J. Trop. Med. Hyg. 84:923–928.
13.
LonchelC.M., MeexC., Gangoué-PiébodjiJ., et al.2012. Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect. Dis. 12:53.
14.
AlabiA.S., FrielinghausL., KabaH., et al.2013. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa. BMC Infect. Dis. 13:455.
15.
YalaJ.F., Mabika MabikaR., BisseyeC., and KengueleH.. 2016. Phenotypic and genotypic characterization of extended-spectrum-beta-lactamases producing-Enterobacteriaceae (ESBLE) in patients attending Omar Bongo Ondimba military hospital at Libreville (Gabon). Curr. Res. Microbiol. Biotechnol. 4:944–949.
16.
ScherbaumM., KöstersK., MürbethR.E, et al.2014. Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon. BMC Infect. Dis. 14:124.
17.
SchaumburgF., AlabiA., KokouC., et al.2013. High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon. J. Antimicrob. Chemother. 68:2140–2143.
JarlierV., NicolasM.H, FournierG., and PhilipponA.. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Clin. Infect. Dis. 10:867–878.
20.
DallenneC., Da CostaA., DecréD., FavierC., and ArletG.. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65:490–495.
21.
PoirelL., WalshT.R, CuvillierV., and NordmannP.. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–123.
22.
CiesielczukH., HornseyM., ChoiV., WoodfordN., and WarehamD.W.. 2013. Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J. Med. Microbiol. 62:1823–1827.
23.
GuoX., DillonB.B, GinnA.N, WiklendtA.M, PartridgeS.R, and IredellJ.R.. 2014. Simple multiplex real-time PCR for rapid detection of common 16S rRNA methyltransferase genes. Diagn. Microbiol. Infect. Dis. 80:29–31.
24.
ClermontO., ChristensonJ.K, DenamurE., and GordonD.. 2013. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ. Microbiol. Rep. 5:58–65.
25.
Gangoué-PiébojiJ., BedenicB., Koulla-ShiroS., et al.2005. Extended-spectrum-β-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J. Clin. Microbiol. 43:3273–3277.
26.
BercionR., Mossoro-KpindeD., ManirakizaA., and Le FaouA.. 2009. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. J. Infect. Dev. Ctries. 3:187–190.
27.
OgboluD.O., DainiO.A, OgunledunA., AlliA.O, and WebberM.A.. 2011. High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Int. J. Antimicrob. Agents, 37:62–66.
28.
OuedraogoA.S., SanouM., KissouA., et al.2016. High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect. Dis. 16:326.
29.
SharifM.R., SoltaniB., MoravvejiA., EramiM., and SoltaniN.. 2016. Prevalence and risk factors associated with extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae isolates in hospitalized patients in Kashan (Iran). Electron. Physician, 8:2081.
30.
Réseau BMR-Raisin. 2009. Surveillance des bactéries multirésistantes dans les établissements de santé en France. Évolution 2002:26 (In language.).
31.
SondaT., KumburuH., Van ZwetselaarM., et al.2016. Meta-analysis of proportion estimates of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in East Africa hospitals. Antimicrob. Resist. Infect. Control, 5:18.
32.
AgyekumA., Fajardo-LubiánA., AnsongD., PartridgeS.R, AgbenyegaT., and IredellJ.R.. 2016. blaCTX-M-15 carried by IncF-type plasmids is the dominant ESBL gene in Escherichia coli and Klebsiella pneumoniae at a hospital in Ghana. Diagn. Microbiol. Infect. Dis. 84:328–333.
33.
FilippiniM., OrtizL.G, and MasieroG.. 2013. Assessing the impact of national antibiotic campaigns in Europe. Eur. J. Health Econ. 14:587–599.
34.
MahamatO.O., LounnasM., HideM., et al.2019. High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals. BMC Infect. Dis. 19:205.
35.
ToudjiA.G., DjeriB., KarouS.D, TigossouS., AmeyapohY., and De SouzaC.. 2017. Prévalence des souches d'entérobactéries productrices de bêta-lactamases à spectre élargi isolées au Togo et de leur sensibilité aux antibiotiques. Int. J. Biol. Chem. Sci. 11:1165–1177 (In language.).
36.
ThabitA.G., El-KhamissyT.R, IbrahimM.A, and AttiaA.E.. 2011. Detection of extended-spectrum β-lactamase enzymes (ESBLs) produced by Escherichia coli urinary pathogens at Assiut University Hospital. Bull. Pharm. Sci. (Assiut University), 34:93–103.
37.
KaderA.A., and KumarA.. 2005. Prevalence and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann. Saudi Med. 25:239–242.
38.
HerindrainyP., RandrianirinaF., RatovosonR., et al.2011. Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar. PLoS One, 6:e22738.
39.
MahamatO.O., TidjaniA., LounnasM., et al.2019. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad. Antimicrob. Resist. Infect. Control, 8:1–7.
40.
BerthodD., PougetR., San MillánD., and TroilletN.. 2012. Entérobactéries résistantes: explosion des beta-lactamases à spectre élargi [Resistant enterobacteria: explosion of extended-spectrum beta-lactamases]. Rev. Méd. Suisse, 8:1925–1929 (In language.).
41.
MoutachakkirM., ChinboM., ElkhoudriN., and SoraaN.. 2015. La résistance aux antibiotiques chez les entérobactéries uropathogènes en milieu pédiatrique au CHU de Marrakech. J. de pédiatrie et de puéric. 28:16–22 (In language.).
42.
JacobG.2010. Emergence des entérobactéries sécrétrices de bêta-lactamases à spectre élargi. Option/Bio, 21:18–20 (In language.).
43.
LeotardS., and NegrinN.. 2010. Épidémiologie des entérobactéries sécrétrices de bêta-lactamases à spectre étendu (E-BLSE) au centre hospitalier de Grasse (2005–2008). Pathol. Biol. 58:35–38 (In language.).
44.
GuessenndN., BremontS., GbononV., et al.2008. Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast. Pathol. Biol. 56:439–446 (In language.).
45.
NordmannP., and MammeriH.. 2007. Résistance plasmidique aux quinolones. Antibiotiques, 9:246–253 (In language.).
46.
CohenR., GilletY., and FayeA.. 2012. Synthesis of management of urinary tract infections in children. Arch. Pediatr. 19:S124–S128.
47.
SchwaberM.J., Klarfeld-LidjiS., Navon-VeneziaS., SchwartzD., LeavittA., and CarmeliY.. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob. Agents Chemother. 52:1028–1033.
48.
LauplandK.B., ParkinsM.D, ChurchD.L, et al.2005. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-β-lactamase (MBL)–producing strains. J. Infect. Dis. 192:1606–1612.
49.
LecaillonE., BoixadosM., DelpechN., et al.1993. Emergence de Proteus mirabilis et Klebsiella pneumoniae possédant une BLSE: traitement et suivi. Méd. Mal. Infect. 23:427–430 (In language.).
50.
Woerther, P.-L. 2012. Emergence, circulation and molecular determinants of extended spectrum β-lactamase (ESBL) producing strains of enterobacteria in populations subjected to varying selection pressures [in French]. University Paris 7, Paris, France.
51.
SaravananM., RamachandranB., and BarabadiH.. 2018. The prevalence and drug resistance pattern of extended spectrum β–lactamases (ESBLs) producing Enterobacteriaceae in Africa. Microb. Pathog. 114:180–192.
52.
ManyahiJ., MoyoS.J, TellevikM.G, et al.2017. Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital-and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania. BMC Infect. Dis. 17:282.
53.
PeiranoG., and J.D. Pitout. Extended-spectrum β-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options. Drugs, 2019:1–13.
54.
WoertherP.-L., BurdetC., ChachatyE., and AndremontA.. 2013. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin. Microbiol. Rev. 26:744–758.
55.
RibeiroT.G., Â. Novais, PeixeL., and MachadoE.. 2016. Atypical epidemiology of CTX-M-15 among Enterobacteriaceae from a high diversity of non-clinical niches in Angola. J. Antimicrob. Chemother. 71:1169–1173.
56.
NabtiL.Z., SahliF., RadjiN., et al.2019. High prevalence of multidrug-resistant Escherichia coli in urine samples from inpatients and outpatients at a Tertiary Care Hospital in Sétif, Algeria. Microb. Drug Resist. 25:386–393.
57.
BabuR., KumarA., KarimS., et al.2016. Faecal carriage rate of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up. J. Glob. Antimicrob. Resist. 6:150–153.
58.
Tani, Z.B.A.-K., and ArletG.. 2014. Actualité de la résistance aux antibiotiques chez les bacilles à Gram négatif en Algérie. Pathol. Biol. 62:169–178 (In language.).
59.
SmatiM., ClermontO., Le GalF., et al.2013. Real-time PCR for quantitative analysis of human commensal Escherichia coli populations reveals a high frequency of subdominant phylogroups. Appl. Environ. Microbiol. 79:5005–5012.
